Okamoto Y, Tsurunaga T, Ueda M, Yamada T, Ueki M, Sugimoto O
Department of Obstetrics and Gynecology, Osaka Medical College.
Nihon Sanka Fujinka Gakkai Zasshi. 1993 Jun;45(6):566-70.
Intercellular adhesion molecule-1(ICAM-1), one of the adhesion molecules, plays an important role in target-cell lysis by immune cells. In this study we examined the expression of ICAM-1 in 15 cases of cervical cancer. We also examined ICAM-1 expression on cervical cancer cell lines in response to cytokines. Immunohistochemistry revealed expression (4 positive among 15 cases) of ICAM-1 in cervical cancer. Furthermore, the expression of ICAM-1 on cervical cancer was correlated with the degree of mononuclear cell infiltration, bearing CD3. On the other hand, the expression of ICAM-1 was not correlated with Class I or Class II antigens in cervical cancer. The expression of ICAM-1 on cervical cancer cell lines was augmented by in vitro treatment with interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha. These results suggest that the expression of ICAM-1 on cervical cancer might be modified by cytokines, and ICAM-1 expression on cervical cancer might augment the host immune reaction. So it will be possible to use cytokines in immunotherapy.
细胞间黏附分子-1(ICAM-1)是黏附分子之一,在免疫细胞介导的靶细胞裂解中起重要作用。在本研究中,我们检测了15例宫颈癌组织中ICAM-1的表达情况。我们还检测了宫颈癌细胞系在细胞因子作用下ICAM-1的表达变化。免疫组织化学显示宫颈癌组织中有ICAM-1表达(15例中有4例阳性)。此外,宫颈癌组织中ICAM-1的表达与单核细胞浸润程度(携带CD3)相关。另一方面,宫颈癌组织中ICAM-1的表达与I类或II类抗原无关。体外使用干扰素(IFN)-γ和肿瘤坏死因子(TNF)-α处理可增强宫颈癌细胞系中ICAM-1的表达。这些结果表明,细胞因子可能会调节宫颈癌组织中ICAM-1的表达,而宫颈癌组织中ICAM-1的表达可能会增强宿主免疫反应。因此,在免疫治疗中使用细胞因子是可行的。